An in vitro diagnostic blood test used to detect and monitor solid tumor cancers by measuring Fibrin and Fibrinogen Degradation Products in the blood.

A proprietary cancer vaccine technology designed to enhance the immune system's ability to destroy cancer cells by incorporating genes into tumor cells.